Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000164694 | SCV000215361 | benign | Hereditary cancer-predisposing syndrome | 2014-06-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000484207 | SCV000564747 | likely benign | not specified | 2017-07-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000164694 | SCV000903165 | benign | Hereditary cancer-predisposing syndrome | 2017-05-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311125 | SCV001501174 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001487028 | SCV001691511 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001311125 | SCV002009426 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001311125 | SCV002046152 | likely benign | not provided | 2023-02-21 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000164694 | SCV002537820 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-24 | criteria provided, single submitter | curation | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492392 | SCV004240278 | likely benign | Breast and/or ovarian cancer | 2023-02-22 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000083218 | SCV000115292 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000083218 | SCV000145371 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2002-06-20 | no assertion criteria provided | clinical testing | |
Brotman Baty Institute, |
RCV000083218 | SCV001237813 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro |